Register to view the archived recording here.
Epigenomics Preps for European Launch of RT-PCR Lung Cancer Dx after Clinical Trial Validation
Epigenomics' PCR-based lung cancer reflex diagnostic test has been validated in a key clinical trial, clearing the way for the test to receive the CE Mark for in vitro diagnostics and for the company to launch the test in Europe in coming weeks.
New to GenomeWeb? Register here quickly.